1. Home
  2. PLAB vs FTRE Comparison

PLAB vs FTRE Comparison

Compare PLAB & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

N/A

Current Price

$27.57

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

N/A

Current Price

$20.28

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLAB
FTRE
Founded
1969
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
PLAB
FTRE
Price
$27.57
$20.28
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
★ $41.33
$23.63
AVG Volume (30 Days)
782.1K
★ 2.0M
Earning Date
12-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.09
N/A
EPS
★ 1.76
N/A
Revenue
$535,276,000.00
★ $2,723,400,000.00
Revenue This Year
$2.20
N/A
Revenue Next Year
$2.81
$3.21
P/E Ratio
$15.81
★ N/A
Revenue Growth
★ 18.77
1.00
52 Week Low
$20.05
$8.55
52 Week High
$56.00
$26.16

Technical Indicators

Market Signals
Indicator
PLAB
FTRE
Relative Strength Index (RSI) 45.19 43.94
Support Level $24.92 $19.36
Resistance Level $29.89 $21.25
Average True Range (ATR) 1.22 1.48
MACD 0.05 -0.35
Stochastic Oscillator 50.31 17.94

Price Performance

Historical Comparison
PLAB
FTRE

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: